Targeting SCF E3 Ligases for Cancer Therapies
Author:
Publisher
Springer Singapore
Link
http://link.springer.com/content/pdf/10.1007/978-981-15-1025-0_9
Reference219 articles.
1. Adamson A, Lin Z, Perez-Ordonez B, Jordan R, Tripp S, Perkins S et al (2001) Expression of Skp2, a p27 ubiquitin ligase in malignant lymphoma: correlation with p27 and proliferation index. Mod Pathol 14(1):154a. https://doi.org/10.1182/blood.V100.8.2950
2. Akhoondi S, Sun D, von der Lehr N, Apostolidou S, Klotz K, Maljukova A et al (2007) FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res 67(19):9006–9012. https://doi.org/10.1158/0008-5472.CAN-07-1320
3. Akhoondi S, Lindstrom L, Widschwendter M, Corcoran M, Bergh J, Spruck C et al (2010) Inactivation of FBXW7/hCDC4-beta expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer. Breast Cancer Res 12(6). https://doi.org/10.1186/Bcr2788
4. Andreu EJ, Lledo E, Poch E, Ivorra C, Albero MP, Martinez-Climent JA et al (2005) BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27 (Kip1) degradation and proliferation of chronic myelogenous leukemia cells. Cancer Res 65(8):3264–3272. https://doi.org/10.1158/0008-5472
5. Arbini AA, Greco M, Yao JL, Bourne P, Marra E, Hsieh JT et al (2011) Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer. Am J Pathol 178(5):2367–2376. https://doi.org/10.1016/j.ajpath.2011.01.050
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A patent review of SCF E3 ligases inhibitors for cancer：Structural design, pharmacological activities and structure–activity relationship;European Journal of Medicinal Chemistry;2024-11
2. Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27KIP1 Regulation;Medicina;2024-07-18
3. FBXL18 is required for ovarian cancer cell proliferation and migration through activating AKT signaling;American Journal of Translational Research;2024
4. Unraveling role of ubiquitination in drug resistance of gynecological cancer;American Journal of Cancer Research;2024
5. Glucose-induced CRL4COP1-p53 axis amplifies glycometabolism to drive tumorigenesis;Molecular Cell;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3